Skip to content
Investors and analysts are invited to
attend a virtual investor presentation
and Q&A which will provide greater
understanding of our business and
outlook following the disposal of our
European Thrombosis Business.
Click to view our
Investor Day webcast

Aspen USA

Aspen Pharma USA Inc., located in Bridgewater, NJ, provides a portfolio of branded oncology products addressing the chronic lymphocytic leukemia (cll), Small Lymphocytic Lymphoma (SLL), chronic myeloid leukemia (cml) and acute nonlymphocytic leukemias (ANL) indications.

These products have been FDA approved and successfully marketed in the USA for several years. We play an important role in contributing to the health and wellbeing of people throughout the world, and continue to innovate and bring value to our patients.

Scroll To Top